Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2021.10.045.][This corrects the article DOI: 10.1016/j.bioactmat.2021.09.001.][This corrects the article DOI: 10.1016/j.bioactmat.2020.05.005.][This corrects the article DOI: 10.1016/j.bioactmat.2020.06.024.][This corrects the article DOI: 10.1016/j.bioactmat.2023.01.005.][This corrects the article DOI: 10.1016/j.bioactmat.2021.10.047.][This corrects the article DOI: 10.1016/j.bioactmat.2022.11.011.][This corrects the article DOI: 10.1016/j.bioactmat.2020.09.004.][This corrects the article DOI: 10.1016/j.bioactmat.2021.02.006.][This corrects the article DOI: 10.1016/j.bioactmat.2024.01.014.][This corrects the article DOI: 10.1016/j.bioactmat.2022.04.015.][This corrects the article DOI: 10.1016/j.bioactmat.2020.10.013.][This corrects the article DOI: 10.1016/j.bioactmat.2020.11.031.][This corrects the article DOI: 10.1016/j.bioactmat.2020.08.013.][This corrects the article DOI: 10.1016/j.bioactmat.2022.03.022.][This corrects the article DOI: 10.1016/j.bioactmat.2024.02.019.][This corrects the article DOI: 10.1016/j.bioactmat.2023.07.021.][This corrects the article DOI: 10.1016/j.bioactmat.2021.10.037.][This corrects the article DOI: 10.1016/j.bioactmat.2020.11.019.][This corrects the article DOI: 10.1016/j.bioactmat.2020.12.003.][This corrects the article DOI: 10.1016/j.bioactmat.2021.01.032.][This corrects the article DOI: 10.1016/j.bioactmat.2020.12.026.][This corrects the article DOI: 10.1016/j.bioactmat.2021.08.028.][This corrects the article DOI: 10.1016/j.bioactmat.2019.03.002.][This corrects the article DOI: 10.1016/j.bioactmat.2020.08.019.][This corrects the article DOI: 10.1016/j.bioactmat.2020.06.008.][This corrects the article DOI: 10.1016/j.bioactmat.2020.11.015.][This corrects the article DOI: 10.1016/j.bioactmat.2021.04.042.][This corrects the article DOI: 10.1016/j.bioactmat.2021.05.028.][This corrects the article DOI: 10.1016/j.bioactmat.2022.05.016.][This corrects the article DOI: 10.1016/j.bioactmat.2022.06.014.][This corrects the article DOI: 10.1016/j.bioactmat.2020.07.017.][This corrects the article DOI: 10.1016/j.bioactmat.2020.04.004.][This corrects the article DOI: 10.1016/j.bioactmat.2020.12.014.][This corrects the article DOI: 10.1016/j.bioactmat.2021.12.020.][This corrects the article DOI: 10.1016/j.bioactmat.2020.09.025.][This corrects the article DOI: 10.1016/j.bioactmat.2020.08.023.][This corrects the article DOI: 10.1016/j.bioactmat.2021.05.019.][This corrects the article DOI: 10.1016/j.bioactmat.2020.11.012.][This corrects the article DOI: 10.1016/j.bioactmat.2022.05.035.][This corrects the article DOI: 10.1016/j.bioactmat.2023.12.028.][This corrects the article DOI: 10.1016/j.bioactmat.2021.06.013.][This corrects the article DOI: 10.1016/j.bioactmat.2021.09.028.][This corrects the article DOI: 10.1016/j.bioactmat.2020.07.009.][This corrects the article DOI: 10.1016/j.bioactmat.2020.07.001.][This corrects the article DOI: 10.1016/j.bioactmat.2022.05.020.][This corrects the article DOI: 10.1016/j.bioactmat.2020.11.002.].

Correction to: AI (Re)Defining Pharmaceutical Exclusivities, by Jonathan Kimball and Srividhya Ragavan, Biotechnol Law Rep 2022;41(1):23–29; doi: 10.1089/blr.2021.29257.sr

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction to: Broad Geographic and Bi-Partisan Support of Industrial Biotechnology Indicates Timing May Be Right for Incentive Legislation, by Danielson and McKay Ind Biotechnol 2023;19(4):195–200; doi: 10.1089/ind.2023.29319.nda

Corrigendum to: Chloro-s-triazenes-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations

Erratum regarding missing ethical statements in previously published articles

Erratum: Error in Subtitle

Erratum: Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes 2023;41:467-473

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics 2024, 15, 2777

Correction: Yu et al. Achieving Effective Multimodal Imaging with Rare-Earth Ion-Doped CaF2 Nanoparticles. Pharmaceutics 2022, 14, 840

Correction: Identification, isolation, structural characterisation, synthesis and in silico toxicity prediction of the alkaline hydrolytic degradation product of brivaracetam by using LC-PDA, preparative HPLC, LC/HESI/LTQ, FTIR, and 1H NMR

Erratum regarding missing declaration of competing interest statements in previously published articles

Erratum regarding missing ethics approval and consent to participate statements in previously published articles

Correction to "The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy"

Correction: Guidelines, Consensus Statements, and Standards for the Use of Artificial Intelligence in Medicine: Systematic Review

Author Correction to ‘approved HIV Reverse Transcriptase Inhibitors in the Past Decade’ [acta Pharmaceutica Sinica B 12 (2022) 1567–1590]

Correction to “Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II – Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertensin”

Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Erratum regarding missing Declaration of Competing Interest statements in previously published article